Insider · CIK 0001581992

Goddard Glenn

CIK 0001581992 Name as filed on the most recent filing

Filed as Goddard Glenn (26)

38 transaction lines · from 26 filings · filed 2014-01-22 to 2024-01-05 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

38 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2024-01-03 S, Open-market sale Intellia Therapeutics, Inc.NTLA 158,053, disposed Open Form 4 filing 0000950170-24-002511
2023-01-04 S, Open-market sale Intellia Therapeutics, Inc.NTLA 90,309, disposed Open Form 4 filing 0001209191-23-002414
2022-01-01 S, Open-market sale Intellia Therapeutics, Inc.NTLA 113,699, disposed Open Form 4 filing 0001209191-22-015917
2021-09-07 S, Open-market sale Intellia Therapeutics, Inc.NTLA 627,178, disposed Open Form 4 filing 0001209191-21-055347
2021-08-31 S, Open-market sale Intellia Therapeutics, Inc.NTLA 3,973,456, disposed Open Form 4 filing 0001209191-21-054315
2021-08-30 S, Open-market sale Intellia Therapeutics, Inc.NTLA 8 lines 810,082, disposed Open Form 4 filing 0001209191-21-054315
2021-08-05 S, Open-market sale Intellia Therapeutics, Inc.NTLA 3 lines 3,021,056, disposed Open Form 4 filing 0001209191-21-050225
2015-09-24 S, Open-market sale Agios Pharmaceuticals IncAGIO 515,820, disposed Open Form 4 filing 0001209191-15-072320
2015-07-23 S, Open-market sale Agios Pharmaceuticals IncAGIO 843,150, disposed Open Form 4 filing 0001209191-15-062574
2015-07-17 S, Open-market sale Agios Pharmaceuticals IncAGIO 1,478,230, disposed Open Form 4 filing 0001209191-15-061930
2015-05-27 S, Open-market sale Agios Pharmaceuticals IncAGIO 260,629, disposed Open Form 4 filing 0001209191-15-047610
2015-03-16 S, Open-market sale Agios Pharmaceuticals IncAGIO 1,062,400, disposed Open Form 4 filing 0001209191-15-027545
2015-02-13 S, Open-market sale Agios Pharmaceuticals IncAGIO 158,328, disposed Open Form 4 filing 0001209191-15-014615
2015-02-11 S, Open-market sale Agios Pharmaceuticals IncAGIO 181,772, disposed Open Form 4 filing 0001209191-15-012167
2015-02-09 S, Open-market sale Agios Pharmaceuticals IncAGIO 1,587,150, disposed Open Form 4 filing 0001209191-15-012167
2014-11-03 S, Open-market sale Agios Pharmaceuticals IncAGIO 163,420, disposed Open Form 4 filing 0001209191-14-066364
2014-10-01 S, Open-market sale Agios Pharmaceuticals IncAGIO 90,105, disposed Open Form 4 filing 0001209191-14-061799
2014-09-26 S, Open-market sale Agios Pharmaceuticals IncAGIO 989,275, disposed Open Form 4 filing 0001209191-14-060121
2014-09-02 S, Open-market sale Agios Pharmaceuticals IncAGIO 463,000, disposed Open Form 4 filing 0001209191-14-055719
2014-07-01 S, Open-market sale Agios Pharmaceuticals IncAGIO 162,820, disposed Open Form 4 filing 0001209191-14-045511
2014-05-01 S, Open-market sale Agios Pharmaceuticals IncAGIO 84,780, disposed Open Form 4 filing 0001209191-14-031227
2014-04-07 S, Open-market sale Agios Pharmaceuticals IncAGIO 90,340, disposed Open Form 4 filing 0001209191-14-026528
2014-04-01 S, Open-market sale Agios Pharmaceuticals IncAGIO 152,320, disposed Open Form 4 filing 0001209191-14-025630
2014-03-07 S, Open-market sale Agios Pharmaceuticals IncAGIO 541,200, disposed Open Form 4 filing 0001209191-14-018505
2014-03-06 S, Open-market sale Agios Pharmaceuticals IncAGIO 194,333, disposed Open Form 4 filing 0001209191-14-018505
2014-02-18 S, Open-market sale Agios Pharmaceuticals IncAGIO 123,832, disposed Open Form 4 filing 0001209191-14-012651
2014-02-10 S, Open-market sale Agios Pharmaceuticals IncAGIO 182,640, disposed Open Form 4 filing 0001209191-14-009242
2014-01-27 S, Open-market sale Agios Pharmaceuticals IncAGIO 184,051, disposed Open Form 4 filing 0001209191-14-005331
2014-01-21 S, Open-market sale Agios Pharmaceuticals IncAGIO 347,108, disposed Open Form 4 filing 0001209191-14-004379

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
Relationships on this page
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 38
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Goddard Glenn, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001581992

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.